Coauthors of the study include Kamika Reynolds and Kimberly OMalley of the Institute for Health and Jason Roy of the Rutgers School of Public Health.
However, the cost of Semaglutide can be a critical factor for individuals considering this medication
Based on results of the study, 3 items form the 23-item questionnaire were removed to reduce patient burden without sacrificing content validity
Discussion In this review, we synthesised evidence from cardiovascular outcome trials, meta-analyses, and mechanistic studies to evaluate the association between GLP-1 receptor agonist (GLP-1RA) therapy and cerebrovascular outcomes, with a particular focus on stroke risk reduction
Many insurance copays run $150-$300 monthly for brand-name medications
Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS